Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma Network
Adoptive cellular therapy using chimeric antigen receptor T-cell (CART) therapy is currently being evaluated in patients with relapsed / refractory multiple myeloma (MM). The majority of CAR-T cell programs now being tested in clinical trials are targeting B-cell maturation antigen. Several recent p...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
August 22, 2019
|
| In: |
Haematologica
Year: 2019, Jahrgang: 104, Heft: 12, Pages: 2358-2360 |
| ISSN: | 1592-8721 |
| DOI: | 10.3324/haematol.2019.224204 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.3324/haematol.2019.224204 Verlag: http://www.haematologica.org/content/104/12/2358 
|
| Verfasserangaben: | Philippe Moreau, Pieter Sonneveld, Mario Boccadoro, Gordon Cook, Ma Victoria Mateos, Hareth Nahi, Hartmut Goldschmidt, Meletios A. Dimopoulos, Paulo Lucio, Joan Bladé, Michel Delforge, Roman Hajek, Heinz Ludwig, Thierry Facon, Jesus F. San Miguel and Hermann Einsele |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1687410135 | ||
| 003 | DE-627 | ||
| 005 | 20230427090144.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200115s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3324/haematol.2019.224204 |2 doi | |
| 035 | |a (DE-627)1687410135 | ||
| 035 | |a (DE-599)KXP1687410135 | ||
| 035 | |a (OCoLC)1341298070 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Moreau, Philippe |e VerfasserIn |0 (DE-588)1095523767 |0 (DE-627)856146544 |0 (DE-576)463046390 |4 aut | |
| 245 | 1 | 0 | |a Chimeric antigen receptor T-cell therapy for multiple myeloma |b a consensus statement from The European Myeloma Network |c Philippe Moreau, Pieter Sonneveld, Mario Boccadoro, Gordon Cook, Ma Victoria Mateos, Hareth Nahi, Hartmut Goldschmidt, Meletios A. Dimopoulos, Paulo Lucio, Joan Bladé, Michel Delforge, Roman Hajek, Heinz Ludwig, Thierry Facon, Jesus F. San Miguel and Hermann Einsele |
| 264 | 1 | |c August 22, 2019 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 15.01.2020 | ||
| 520 | |a Adoptive cellular therapy using chimeric antigen receptor T-cell (CART) therapy is currently being evaluated in patients with relapsed / refractory multiple myeloma (MM). The majority of CAR-T cell programs now being tested in clinical trials are targeting B-cell maturation antigen. Several recent phase I / II trials show promising preliminary results in patients with MM progressing on proteasome inhibitors, immunomodulatory drugs and monoclonal antibodies targeting CD38. CAR-T cell therapy is a potentially life-threatening strategy that can only be administered in experienced centers. For the moment, CAR-T cell therapy for MM is still experimental, but once this strategy has been approved in relapsed/refractory MM, it will become one of the most important indications for this therapy in Europe and world-wide. This manuscript proposes practical considerations for the use of CAR-T cell therapy in MM, and discusses several important issues for its future development. | ||
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Haematologica |d Pavia : Ferrata Storti Foundation, 2014 |g 104(2019), 12, Seite 2358-2360 |h Online-Ressource |w (DE-627)814204899 |w (DE-600)2805244-4 |w (DE-576)424051125 |x 1592-8721 |7 nnas |a Chimeric antigen receptor T-cell therapy for multiple myeloma a consensus statement from The European Myeloma Network |
| 773 | 1 | 8 | |g volume:104 |g year:2019 |g number:12 |g pages:2358-2360 |g extent:3 |a Chimeric antigen receptor T-cell therapy for multiple myeloma a consensus statement from The European Myeloma Network |
| 856 | 4 | 0 | |u https://doi.org/10.3324/haematol.2019.224204 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.haematologica.org/content/104/12/2358 |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20200115 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |e 910000PG102258023X |e 910100PG102258023X |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 999 | |a KXP-PPN1687410135 |e 3575498016 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 15.01.2020"],"language":["eng"],"person":[{"given":"Philippe","family":"Moreau","role":"aut","display":"Moreau, Philippe"},{"given":"Hartmut","display":"Goldschmidt, Hartmut","role":"aut","family":"Goldschmidt"}],"recId":"1687410135","id":{"eki":["1687410135"],"doi":["10.3324/haematol.2019.224204"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Philippe Moreau, Pieter Sonneveld, Mario Boccadoro, Gordon Cook, Ma Victoria Mateos, Hareth Nahi, Hartmut Goldschmidt, Meletios A. Dimopoulos, Paulo Lucio, Joan Bladé, Michel Delforge, Roman Hajek, Heinz Ludwig, Thierry Facon, Jesus F. San Miguel and Hermann Einsele"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"August 22, 2019"}],"relHost":[{"pubHistory":["99.2014 -"],"titleAlt":[{"title":"journal of the European Hematology Association"}],"note":["Gesehen am 27.05.2022"],"language":["eng"],"recId":"814204899","id":{"issn":["1592-8721"],"zdb":["2805244-4"],"eki":["814204899"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Chimeric antigen receptor T-cell therapy for multiple myeloma a consensus statement from The European Myeloma NetworkHaematologica","origin":[{"dateIssuedKey":"2014","publisherPlace":"Pavia","dateIssuedDisp":"2014-","publisher":"Ferrata Storti Foundation"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Haematologica","title_sort":"Haematologica","subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation"}],"part":{"volume":"104","text":"104(2019), 12, Seite 2358-2360","issue":"12","year":"2019","pages":"2358-2360","extent":"3"}}],"physDesc":[{"extent":"3 S."}],"title":[{"title":"Chimeric antigen receptor T-cell therapy for multiple myeloma","subtitle":"a consensus statement from The European Myeloma Network","title_sort":"Chimeric antigen receptor T-cell therapy for multiple myeloma"}]} | ||
| SRT | |a MOREAUPHILCHIMERICAN2220 | ||